Dr. Pasha was one of the first in the United States to utilize a corticosteroid embedded implant in the office (Propel™). This particular implant is designed for those patients who have had prior sinus surgery or have advanced sinus disease such as nasal polyps or severe chronic sinusitis. Within the implant is a steroid (mometasone furoate) that eludes over time reducing the inflammation, scarring, and polyps in the sinuses. The implant is bioabsorbable meaning that after time the implant dissolves over the course of weeks.
The implant can be placed almost painlessly within a few minutes for select patients in the office. No time off work or school is required nor is there any recovery period.
Corticosteroid implants are cutting edge technology and currently will be performed only under research protocols. The Propel sinus implant should not be used in patients with a suspected or confirmed intolerance to mometasone furoate or a known hypersensitivity to lactide, glycolide or caprolactone copolymers.
The Propel Implant, pictured above, expands in the ethmoid sinus, helping the middle turbinate from blocking the sinuses.